Department of Cancer Research and Molecular Medicine, Faculty of Medicine, Norwegian University of Technology and Science, Trondheim, Norway.
Acta Oncol. 2011 Nov;50(8):1175-82. doi: 10.3109/0284186X.2011.604345. Epub 2011 Aug 28.
The aim of this study was to report on early effects of contemporary radiotherapy (RT) on health-related quality of life (HRQOL) and explore treatment-related contributors to the development of fatigue during RT in breast cancer (BC) patients.
Consecutive BC patients (n = 248) referred for postoperative RT at St. Olavs University Hospital in Trondheim, Norway were enrolled from February 2007 to October 2008. Clinical- and treatment data were recorded, and HRQOL were assessed before starting (baseline) and immediately after ending RT using the "EORTC QLQ-C30" and the breast module "EORTC QLQ-BR23". Change scores from baseline were calculated. Predictors of increased fatigue during RT were explored with multiple regression analysis adjusted for relevant confounders.
The global QOL- and all functional scales remained stable, except for "future perspective" which improved significantly during RT. Breast symptoms and fatigue increased significantly during RT. Groups with elevated baseline fatigue remained more stable during RT than those with lower levels at baseline. The body volume receiving 40 Gy or more (V40) was a significant predictor of increased fatigue during RT adjusted for chemotherapy, comorbidity and age (p = 0.035).
Contemporary RT has limited early effects on HRQOL. V40 is a significant predictor of RT-related fatigue.
本研究旨在报告当代放疗(RT)对乳腺癌(BC)患者健康相关生活质量(HRQOL)的早期影响,并探讨与 RT 相关的导致疲劳发展的因素。
2007 年 2 月至 2008 年 10 月,挪威特隆赫姆圣奥拉夫大学医院连续入组了 248 例接受术后 RT 的 BC 患者。记录临床和治疗数据,并在开始 RT 前(基线)和结束 RT 后立即使用“EORTC QLQ-C30”和乳腺癌模块“EORTC QLQ-BR23”评估 HRQOL。计算从基线变化的得分。通过多元回归分析,调整相关混杂因素,探讨 RT 期间疲劳增加的预测因素。
全球 QOL 和所有功能量表保持稳定,除了“未来展望”在 RT 期间显著改善。乳腺症状和疲劳在 RT 期间显著增加。基线疲劳水平较高的组在 RT 期间保持相对稳定,而基线水平较低的组则更不稳定。接受 40Gy 或更高剂量(V40)的体体积是 RT 相关疲劳的一个显著预测因素,调整了化疗、合并症和年龄(p=0.035)。
当代 RT 对 HRQOL 的早期影响有限。V40 是 RT 相关疲劳的一个显著预测因素。